05/19/2026
Living Longer with Cancer: Rethinking Survivorship
Science Will Win
A recent episode of Pfizer's Science Will Win podcast takes a clear-eyed look at what survivorship actually means today, featuring Cancer Nation CEO Shelley Fuld Nasso, breast cancer survivor Bob Riter, and others working at the intersection of cancer care, work, and policy. From the misleading mythology of the five-year survival mark to the invisible toll of returning to "normal life," the episode asks what it takes to truly support the 18 million people living with, through, and beyond cancer.
What They’re Saying: "It's not over when it's over," said Shelley Fuld Nasso. "The treatment is over, but cancer's not over." The episode directly connects survivorship support gaps to the kind of systemic change Cancer Nation has demanded for decades, including reimbursement for Survivorship Care Plans and whole-person care that doesn't end when treatment does.
Go To Section OverviewSeason 6Season 5Season 4Season 3Season 2Season 1HostsTranscriptsAwardsOther PodcastsScience Will Win is an award-winning podcast that takes listeners under the microscope on some of the most promising medical innovations, exploring therapies that have the potential to shape the...